News Releases

July 12, 2019
DEER PARK, Ill. , July 12, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that the U. S Food and Drug Administration ( FDA ) provided Eton’s partner with a
March 14, 2019
FDA Previously Granted DS-200 Fast Track Designation DEER PARK, Ill. , March 14, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), today announced that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration ( FDA ) for DS-200 via the
Displaying 11 - 20 of 21